Introduction {#s1}
============

Nearly half of the human genome is composed of transposable elements (TEs), which are increasingly being recognized not just as parasitic DNA, but as an important source of regulatory innovation for the host ([@bib14]; [@bib18]; [@bib67]; [@bib77]). In particular, endogenous retroviruses (ERVs), which comprise about 8% of the human genome, are sequences derived from ancient retroviruses whose germ-line infections have persisted through millions of years of evolution ([@bib17]; [@bib39]; [@bib34]). At the time of endogenization, ERVs, like all retroviruses, contain 5ʹ and 3ʹ long terminal repeats (LTRs) that flank open reading frames encoding retroviral proteins; over time, these LTRs accumulate mutations and often undergo homologous recombination, which reduces them to so-called 'solo' LTRs ([@bib21]; [@bib40]; [@bib72]; [@bib89]). In their capacity as retroviral promoters, LTRs are enriched for transcription factor motifs and thus are a particularly fertile substrate for evolving new regulatory elements that can be exapted for host gene regulation. Many examples of such exaptations now exist, for example: in the mouse two-cell (2C) stage embryo, MERVL elements serve as alternative promoters for a subset of mouse 2C genes ([@bib53]), while LTRs of a human ERV, MER41, can function as interferon-inducible enhancers ([@bib13]). Epigenomic mapping studies detected cell type-selective active enhancer signatures at thousands of LTRs, suggesting that acquisition of tissue-specific or inducible regulatory functions by these elements is a widespread phenomenon that may have profound effects on host gene regulatory networks ([@bib7]; [@bib15]; [@bib33]; [@bib44]; [@bib54]; [@bib74]; [@bib78]; [@bib79]; [@bib38]; [@bib82]). Furthermore, emerging evidence suggests that a large proportion of primate-specific enhancer/promoter sequences, as well as those that changed their activity most recently, since the separation of humans from chimpanzees, originate from TEs ([@bib36]; [@bib62]; [@bib67]; [@bib79]). Thus, understanding the functional impact of TEs on gene regulation is essential for comprehending the emergence of primate- and human-specific traits.

Despite evidence suggesting the importance of LTRs and other TEs in rewiring gene regulatory networks, most current studies are either correlative or focus on the analysis of individual insertions, rather than on systematically perturbing specific TE classes, with one notable exception of a report utilizing transcription activator-like effector (TALE) fused to effector domains for functional perturbations of mouse LINE1 elements ([@bib35]). This knowledge gap is associated with technical challenges, as LTR subfamilies are often present in hundreds or thousands of copies, which are highly repetitive, but, due to accumulated mutations, sufficiently sequence-divergent to prevent their recognition by a single short-sequence-dependent factor, such as a zinc finger protein or CRISPR guide RNA (gRNA). To overcome these limitations and develop a strategy for systematic interrogation of TE function, we leveraged our recently developed method for gRNA multiplexing called CARGO (Chimeric Array of gRNA Oligos), which allows for the introduction of tens of gRNAs into single cells ([@bib23]).

Here, we couple CARGO with nuclease dead Cas9 (dCas9) fused to an activation or repression domain (CRISPRa and CRISPRi, respectively) ([@bib10]; [@bib20]) to facilitate transcriptional induction or silencing of HERVK LTR5HS elements en masse. Among human ERVs, HERVK (HML-2) is of particular interest, as it is the most recently endogenized retrovirus, which infected the primate lineage both before and after the human-chimpanzee divergence and retained many intact proviruses with coding potential ([@bib1]; [@bib5]; [@bib55]). This ERV class contains integrations so recent that polymorphic insertions across the human population exist ([@bib4]; [@bib71]; [@bib84]). All human-specific and human-polymorphic HERVK insertions are associated with a specific LTR5 family subclass, LTR5HS, present in 697 copies in the human genome (hg38 assembly) ([@bib26]; [@bib73]). We recently showed that HERVK is transcriptionally activated in human preimplantation embryos and in naïve, but not primed, human embryonic stem cells (hESCs) ([@bib22]). Naïve hESCs model an early, preimplantation stage of the human blastocyst, characterized by global DNA hypomethylation similar to that observed in the inner cell mass, with transcriptional profiles and epigenetic landscapes different from those of primed hESCs, which are most similar to a later, postimplantation stage of the blastocyst ([@bib2]; [@bib91]). Embryonic activation of HERVK can also be modeled in human embryonal carcinoma NCCIT cells, which exhibit both pluripotent and tumorigenic characteristics, but, unlike naïve hESCs, are easy to maintain and manipulate. Similarly to naïve hESCs and preimplantation embryos, NCCIT cells express pluripotency transcription factors and are characterized by DNA hypomethylation and high expression of HERVK-derived transcripts and proteins ([@bib6]; [@bib22]; [@bib29]). Transcriptional reactivation of HERVK in NCCIT is associated with the acquisition of enhancer-like chromatin signatures at LTR5HS elements, raising the possibility that these elements may influence host gene expression programs ([@bib22]).

We now demonstrate that a CARGO-based CRISPRa/CRISPRi strategy facilitates robust and specific targeting of dCas9 to \~90% of LTR5HS elements throughout the human genome for efficient activation or repression of HERVK transcripts and proteins. Moreover, perturbation of LTR5HS function by recruitment of an activator or a repressor leads to the reciprocal up- and down-regulation of nearly 300 human genes, along with widespread effects on the chromatin landscape surrounding the promoters of these genes and LTR5HS insertions. Remarkably, these effects on host gene expression occur over long genomic ranges, indicating that LTR5HS elements function as distal enhancers for a substantial number of genes. In agreement, deletion of select LTR5HS elements confirms their strong contribution to host gene transcription. These LTR5HS-regulated genes are preferentially expressed in naïve relative to primed hESCs and their transcripts are also elevated in developing human blastocysts as compared to those of rhesus macaque, a primate species that does not contain LTR5HS insertions. These observations suggest that recent HERVK endogenization has contributed to the establishment of unique gene expression patterns in preimplantation embryos of humans and other apes. Altogether, our work provides a novel and broadly applicable strategy for functional manipulation of specific TE classes across the genome and supports a pervasive role of LTRs as embryonic gene enhancers.

Results {#s2}
=======

CARGO-CRISPRa/CRISPRi system for manipulating function of transposable elements across the genome {#s2-1}
-------------------------------------------------------------------------------------------------

To investigate the role of HERVK LTR5HS insertions in the regulation of embryonic gene expression and, more broadly, to establish a proof of principle for using CARGO to simultaneously target hundreds of repetitive elements interspersed across the genome, we designed a CARGO array with 12 distinct gRNA transcriptional units, altogether predicted to recognize \~91% (635/697) of LTR5HS integrations in the human genome (hg38 assembly) when allowing zero mismatches between gRNA sequences and LTR5HS sequences ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We computationally predict that many insertions are recognized by multiple gRNAs, with a maximum of nine gRNAs expected to target any single insertion. For example, at zero mismatches, \~87% of LTR5HS insertions are targeted by at least two gRNAs, and \~57% by at least four gRNAs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), an important consideration given that a single gRNA is often insufficient for robust gene activation/silencing by CRISPRa/CRISPRi ([@bib12]; [@bib59]).

Although our custom scoring algorithm penalized potential gRNAs that target genomic regions other than LTR5HS, we 'masked' the highly related (\~88% sequence similarity) HERVK LTR5A and LTR5B sequences to exclude them from negatively affecting candidate gRNA scores. Consequently, our CARGO array is computationally predicted to exhibit some binding to LTR5A and LTR5B, but should not target other classes of LTRs or other TEs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), including the SVA elements, which are in part derived from the LTR5 sequence ([@bib25]; [@bib57]). With this strategy, we expect 58% (178/306) of LTR5A and 50% (235/472) of LTR5B insertions to be bound when no mismatches are allowed.

We assembled CARGO LTR5HS-targeting arrays using either the *Streptococcus pyogenes* gRNA scaffold (hereafter called LTR5HS Sp) or the *Staphylococcus aureus* gRNA scaffold (LTR5HS Sa). As a non-targeting control, we also assembled a CARGO array with gRNAs that should not pair anywhere in the human genome, with the *S. pyogenes* gRNA scaffold (nontarget Sp). To couple CARGO with CRISPRa/CRISPRi approaches for systematic perturbation of function, we used the human embryonal carcinoma NCCIT model to generate six transgenic cell lines, each expressing one of the three aforementioned CARGO arrays and a doxycycline-inducible *S. pyogenes* dCas9 fused to either the strong transactivation domain VPR (dCas9-VPR; CRISPRa) or to a repressive KRAB domain (dCas9-KRAB; CRISPRi) ([@bib10]; [@bib20]) ([Figure 1A](#fig1){ref-type="fig"}). Only cells expressing the LTR5HS Sp array will recruit dCas9 fusion proteins to the target regions, for either activation (dCas9-VPR) or repression (dCas9-KRAB) of HERVK/LTR5HS transcription ([Figure 1B](#fig1){ref-type="fig"}). By contrast, LTR5HS Sa gRNAs will not complex with the *S. pyogenes* dCas9, and thus cells with the LTR5HS Sa array serve as a control for overexpression of LTR5HS-derived short RNAs. Finally, in nontarget Sp cell lines, the gRNAs will form a complex with dCas9, but will not bind the genome (at least not in a sequence-dependent manner), thereby serving as a control for the presence of RNA-loaded dCas9 complexes ([Figure 1B](#fig1){ref-type="fig"}).

![Control of HERVK/LTR5HS expression by CARGO-CRISPRa/CRISPRi.\
(**A**) Schematic of experimental strategy for generation of NCCIT human embryonal carcinoma cell lines expressing CARGO arrays and indicated *S. pyogenes* dCas9 fusion proteins (SpdCas9). CARGO array schematic adapted from ([@bib23]). (**B**) Design of three CARGO arrays used in this study. CARGO arrays contain 12 distinct transcriptional units expressing gRNAs targeting LTR5HS or nontargeting gRNAs, with a scaffold sequence from the indicated bacterial species. Predicted effect of each CARGO-SpdCas9 combination on HERVK expression is shown. (**C--D**) RT-qPCR (**C**) or western blot (**D**) analysis of LTR5HS or HERVK proviral genes in NCCIT cells induced with dCas9-VPR (CRISPRa) or dCas9-KRAB (CRISPRi) and one of three CARGO arrays. In (**C**), error bars show standard deviation, and expression is shown relative to *RPL13A*, and normalized such that the average of LTR5HS Sa and nontarget Sp conditions is set to 1. \*\*\*\*p value \< 0.0001, one-sided *t*-test. In (**D**), different exposure times have been used in left and right WB panels to allow for visualization of protein level changes upon CRISPRa and CRISPRi, respectively.](elife-35989-fig1){#fig1}

We next induced expression of the respective dCas9 fusion proteins with doxycycline in all six NCCIT cell lines, and assayed expression of LTR5HS-driven transcripts using RT-qPCR ([Figure 1C](#fig1){ref-type="fig"}). While most of the LTR5HS elements in the genome exist as solo LTRs, a subset remains associated with protein-encoding proviral sequences. We therefore also examined expression of HERVK transcripts encoding *env*, *gag*, and *pro*, as well as protein levels of Env. We found that although HERVK is already highly expressed in NCCIT cells, levels of both HERVK proviral transcripts and LTR5HS-derived transcripts further increase between 10- and 15-fold in the dCas9-VPR activating lines in the recruitment condition LTR5HS Sp, as compared to the control conditions LTR5HS Sa and nontarget Sp ([Figure 1C](#fig1){ref-type="fig"}). Conversely, in the dCas9-KRAB expressing lines, HERVK transcript expression decreases by over 98-fold in the binding condition LTR5HS Sp, compared to the control conditions LTR5HS Sa and nontarget Sp ([Figure 1C](#fig1){ref-type="fig"}). Interestingly, observed repression levels are generally as strong as or stronger than those previously reported in CRISPRi experiments with silencing of active single copy loci, attesting to the efficacy of our system. In agreement with effects on transcript expression, we also observed global increases and decreases in HERVK Env protein levels with, respectively, dCas9-VPR and dCas9-KRAB recruitment to LTR5HS ([Figure 1D](#fig1){ref-type="fig"}). Altogether, CARGO-CRISPRa/CRISPRi provides a robust system for manipulating the function of highly repetitive TEs such as HERVK.

dCas9 selectively binds the majority of LTR5HS insertions {#s2-2}
---------------------------------------------------------

We next employed chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) to characterize the prevalence and specificity of dCas9 targeting to individual LTR5HS instances across the genome. We derived NCCIT lines stably expressing doxycycline-inducible dCas9 fused to EGFP (dCas9-GFP), and one of the three CARGO arrays: the recruitment (LTR5HS Sp) array or the two control (LTR5HS Sa or nontarget Sp) arrays. For each CARGO array condition, we performed ChIP-seq using three antibodies: one against Cas9, and two against GFP (example UCSC genome browser tracks are shown in [Figure 2A](#fig2){ref-type="fig"}). In order to avoid artifacts associated with antibody cross-reactivity, we focused our analysis on peaks called with all three antibodies. Using paired-end 150 bp sequencing allowed us to map obtained signals to individual instances of HERVK in the genome ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We identified 1178 high-confidence peaks for the recruitment (LTR5HS Sp) condition, while for the control conditions we called 72 peaks (LTR5HS Sa) and 0 peaks (nontarget Sp) ([Figure 2B](#fig2){ref-type="fig"}), suggesting that most peaks in the LTR5HS Sp condition are due to site-specific targeting by CARGO. In agreement, the majority of dCas9 binding occurs at LTR5HS sites (591 peaks, corresponding to 85% of LTR5HS elements) or the computationally predicted and highly sequence related LTR5A/5B/5 sites (343 peaks, corresponding to 53%, 41%, and 19% of, respectively, LTR5A, LTR5B, and LTR5 instances), and is selective for the LTR5HS Sp array condition ([Figure 2B,C](#fig2){ref-type="fig"}). These HERVK LTR5 peaks lie almost entirely in intergenic (\~68.6%) and intragenic (\~30.6%) regions, with very few (\~0.8%) overlapping with promoters ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The remaining 244 non-LTR peaks we classify as off-targets, and these are distributed evenly between intergenic and intragenic sites. Some of these peaks (33/244, \~14%) are legitimate Watson-Crick base-pairing off-targets of the CRISPR gRNAs in the CARGO array to the human genome sequence, when allowing for up to three mismatches between gRNA and genome sequence. The rest, we believe, are simply non-specific binding sites, though some may be legitimate off-targets when permitting more than three mismatches; indeed, it is known that gRNA-to-target mismatches are tolerated beyond this threshold, especially when these mismatches are outside of the 5 bp 'seed' sequence immediately adjacent to the PAM site ([@bib45]; [@bib85]).

![Robust and selective dCas9 targeting to LTR5HS via CARGO.\
(**A**) Representative UCSC hg38 genome browser tracks showing ChIP-seq profiles for dCas9 performed with three different antibodies (Cas9, GFP Abcam, GFP Invitrogen) from NCCIT cells expressing one of the three CARGO arrays (LTR5HS Sp, LTR5HS Sa, nontarget Sp; colored as in [Figure 1](#fig1){ref-type="fig"}). Regions around LTR5HS insertions are highlighted in pink. (**B**) Distribution of dCas9 LTR5HS ChIP-seq peaks called with all three antibodies over HERVK LTRs and known genomic features. (**C**) Heat maps of normalized ChIP-seq signal with three different CARGO arrays using Cas9 antibody. Each row represents a 4 kb window (2 kb in each direction) centered at the middle of the indicated HERVK LTR, with number of insertions of each class shown. Heat map of each LTR is sorted by Cas9 LTR5HS Sp ChIP average signal. (**D**) Percent of each Repeatmasker hg38 repeat class bound by dCas9 ChIP-seq peaks called with all three antibodies. Int, internal proviral sequences; RC, rolling circle; SVA, SINE/VNTR/Alu.](elife-35989-fig2){#fig2}

As would be expected, LTR5HS instances computationally predicted to align with multiple gRNAs had stronger dCas9 ChIP-seq enrichments ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). However, the overall correlation was only moderate (Spearman correlation coefficient ρ = 0.57 at zero mismatches allowed), indicating that the number of pairing gRNAs is not the sole determinant of dCas9 binding strength. Importantly, we did not observe significant binding of dCas9 to other TEs or repetitive sequences, including the SVAs ([Figure 2D](#fig2){ref-type="fig"}). We found only 25 individual SVA insertions (0.43% of 5750 in Repeatmasker hg38) to be bound in this experiment. Together, these data demonstrate that our CARGO-dCas9 strategy enables highly selective targeting of a specific TE class.

Manipulation of chromatin landscape by CRISPRa/CRISPRi {#s2-3}
------------------------------------------------------

We next sought to assess the effect of CRISPRa and CRISPRi on the chromatin landscape of NCCIT cells, specifically around HERVK LTR5HS sequences. To this end, we performed ChIP-seq for the histone modifications H3K27ac, H3K4me3, and H3K9me3 in wild type, parental NCCIT cells, as well as in cells expressing dCas9-VPR or dCas9-KRAB along with the LTR5HS *S. pyogenes* CARGO array (i.e. LTR5HS Sp; targeting condition). We also performed ChIP-seq for dCas9 using the Cas9 antibody described above, in the same three cell populations. As expected, in WT NCCIT cells, which do not express a dCas9 fusion, we did not detect any enrichment of dCas9 signal. We also found that in these cells, a large subset of LTR5HS elements is marked by H3K27ac and H3K4me3, with H3K4me3 showing the expected asymmetric distribution consistent with the direction of LTR-driven transcription ([Figure 3A](#fig3){ref-type="fig"}). Furthermore, LTR5HS insertions generally lack H3K9me3 in WT NCCIT, regardless of the presence or absence of H3K27ac and H3K4me3, suggesting that LTR5HS insertions in these cells escape KRAB-mediated repression, a major mechanism of endogenous retrovirus silencing ([@bib19]; [@bib69]).

![Changes in LTR5HS chromatin landscape upon CARGO-CRISPRa/CRISPRi.\
(**A**) Heat maps of normalized ChIP-seq signal using antibodies against Cas9, H3K27ac, H3K4me3, or H3K9me3. Heat maps for each antibody show wild type NCCIT or NCCIT cells expressing dCas9-VPR or dCas9-KRAB fusion along with LTR5HS Sp CARGO array. Each row represents a 4 kb window (2 kb in each direction) centered at the middle of HERVK LTR5HS. All heat maps are sorted by H3K27ac signal in WT NCCIT. (**B**) UCSC hg38 genome browser tracks showing ChIP-seq profiles for Cas9, H3K27ac, H3K4me3, and H3K9me3, in WT NCCIT, CRISPRa targeting condition (dCas9-VPR), and CRISPRi targeting condition (dCas9-KRAB). LTR5HS insertions are highlighted in pink. Arrows show direction of transcription of coding genes and LTR5HS elements.](elife-35989-fig3){#fig3}

Under CRISPRa and CRISPRi conditions, we detected substantial changes in all three histone marks examined ([Figure 3A](#fig3){ref-type="fig"}, individual LTR5HS examples are shown in [Figure 3B](#fig3){ref-type="fig"}). With CRISPRa, over 90% of LTR5HS elements gain a high level of H3K27 acetylation, with no appreciable change in H3K4me3. In fact, strong gains in H3K27ac occur even at those LTR5HS insertions that have low endogenous acetylation, which may suggest that ectopic enhancer activation is relatively common and efficient with this system. Conversely, with CRISPRi, we observed a reduction in both active marks, H3K27ac and H3K4me3, and a strong concomitant increase in H3K9me3, as expected, given that KRAB repression is mediated by H3K9me3 deposition ([Figure 3A](#fig3){ref-type="fig"}, individual LTR5HS examples are shown in [Figure 3B](#fig3){ref-type="fig"}). Under both CRISPRa and CRISPRi conditions, we found strong signals of dCas9 binding, though enrichments at the corresponding elements were higher with dCas9-VPR than dCas9-KRAB ([Figure 3A](#fig3){ref-type="fig"}). This is likely attributable to the fact that VPR, a strong activation domain, recruits coactivators that promote nucleosomal depletion ([@bib9]), whereas KRAB-mediated H3K9me3 facilitates chromatin compaction ([@bib3]), which may in turn provide, respectively, positive or negative feedback for dCas9 fusion binding, especially given that nucleosomes can impede access of Cas9 to DNA ([@bib32]). Nonetheless, dCas9-KRAB still occupies and mediates H3K9me3 deposition at over 90% of LTR5HS elements ([Figure 3A](#fig3){ref-type="fig"}). Taken together, these data show that a large subset of LTR5HS elements is enriched in active chromatin marks in WT cells, but that targeted recruitment of dCas9 fusions results in widespread effects on the LTR5HS chromatin landscape that are consistent with the predicted activity of the fusion protein.

Reciprocal effects of LTR5HS CRISPRa/CRISPRi on host gene expression {#s2-4}
--------------------------------------------------------------------

CARGO-CRISPRa/CRISPRi allows us to systematically test the impact of LTR5HS activation or repression on the host transcriptome. To do so, we performed RNA-seq on the six cell lines described in [Figure 1](#fig1){ref-type="fig"} after doxycycline induction of dCas9-VPR or dCas9-KRAB. First, we examined transcriptional changes of repetitive elements and found that, as expected, LTR5HS and HERVK transcripts are upregulated by dCas9-VPR recruitment to LTR5HS ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), and downregulated by dCas9-KRAB recruitment to LTR5HS ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We next analyzed expression of non-repetitive genes, and identified 390 transcripts that significantly change in expression (false discovery rate \[FDR\] \< 0.05) with both dCas9-VPR (CRISPRa) and dCas9-KRAB (CRISPRi) ([Figure 4A](#fig4){ref-type="fig"}). Of those, the majority (275 genes, 71%, [Figure 4A](#fig4){ref-type="fig"}, blue points in lower right quadrant) are reciprocally upregulated by CRISPRa and downregulated by CRISPRi, which is consistent both with LTR5HS-dependent regulation, and with the possibility that LTR5HS elements function as enhancers, since activation or repression of an enhancer would be expected to induce or decrease, respectively, expression of a target gene. Some genes were only affected by one of the treatments (i.e. dCas9-VPR only, 3980 genes, 1886 upregulated and 2094 downregulated, in green, or dCas9-KRAB only, 288 genes, 145 upregulated and 143 downregulated, in red, [Figure 4A](#fig4){ref-type="fig"}), and these effects could reflect a genuine contribution of LTR5HS to their regulation. Nonetheless, when we analyzed transcripts with respect to distance from the nearest LTR5HS, grouped by deciles from closest to furthest, we found that the majority of reciprocally affected genes (218/275, 79%) fell within the closest decile, consistent with regulation by LTR5HS ([Figure 4B](#fig4){ref-type="fig"}). Furthermore, the magnitude of expression changes of genes affected by CRISPRa-only or CRISPRi-only is relatively modest: only 40% and 18%, respectively, have a greater than two-fold change in expression in either direction. Most (78% and 60%, respectively) of these CRISPRa-only or CRISPRi-only affected genes fall outside of the first or second decile in distance with respect to the nearest LTR5HS (i.e. within 436 kb of the LTR5HS; compare [Figure 4A and B](#fig4){ref-type="fig"}), suggesting many indirect effects. In contrast, of the 275 genes reciprocally upregulated by CRISPRa and downregulated by CRISPRi, 225 (82%) show greater than two-fold change in expression in at least one condition, and 250 (91%) fall within the first or second decile of distance from the nearest LTR5HS. Therefore, we further focus on the 275 genes that show reciprocal transcriptional effects in CRISPRa/CRISPRi, and we refer to them as LTR5HS-regulated transcripts.

![Reciprocal effects of LTR5HS CARGO-CRISPRa/CRISPRi on host gene expression.\
(**A**) Gene expression log2 fold change of CRISPRi (recruitment vs. control) vs. log2 fold change of CRISPRa (recruitment vs. control). Green, genes affected by CRISPRa alone; red, genes affected by CRISPRi alone; blue, genes affected by both CRISPRa and CRISPRi. Dotted line at lower right quadrant delineates LTR5HS-regulated transcripts reciprocally upregulated by CRISPRa and downregulated by CRISPRi. (**B**) Plot as in (**A**), with genes separated into deciles by distance from nearest LTR5HS insertion. Blue, nearest decile; orange, farthest decile. Distance bins for nearest and farthest decile are shown above and below legend, respectively. (**C--D**) Lower right quadrant of LTR5HS-regulated transcripts in (**A**), with genes significantly upregulated in (**C**) naïve versus primed hESC or (**D**) human preimplantation epiblast shown in black. Data from ([@bib75]; [@bib76]; [@bib87]). (**E**) Log2-transformed expression of LTR5HS-regulated transcripts in single cells of early human and rhesus macaque embryos at indicated stages of embryogenesis. Plots show median (center line), with interquartile range (box) and whiskers show points within 1.5x the interquartile range. \*\*\*p value \< 0.001; n.s. not significant, Wilcoxon-Mann-Whitney test. Of the 275 LTR5HS-regulated transcripts, 193 are one-to-one orthologous genes between human and rhesus. Only expression of these genes was considered in this analysis.](elife-35989-fig4){#fig4}

For these 275 LTR5HS-regulated transcripts, we found that the nearest LTR5HS insertion is upstream of the promoter in 150 cases, and downstream in 125 cases. This finding suggests that even downstream LTR5HS insertions can have a transcriptional effect on the gene, meaning that these insertions do not serve as alternative promoters. Furthermore, since LTR sequences do have a natural orientation, we also examined the relative orientation of the nearest LTR5HS for each of these genes. In the 150 cases in which the nearest LTR5HS insertion is upstream of the promoter, the LTR5HS has the same orientation as the gene (both on Watson strand or both on Crick strand) 83 times, compared to 67 in the opposite orientation. In the 125 cases in which the nearest LTR5HS insertion is downstream of the promoter, the LTR5HS has the same orientation as the gene 48 times, compared to 77 in the opposite orientation. Together, these findings suggest that neither the relative position of the LTR5HS insertion to the promoter, nor its orientation, determines its ability to effect a transcriptional change on the gene in question under CRISPRa or CRISPR, consistent with the putative enhancer function. Furthermore, when we analyzed the RNA-seq data for the presence of chimeric transcripts between LTR5HS and the LTR5HS-regulated genes, we detected an appreciable level (i.e. transcripts per million \[TPM\] \> 1) of chimeric transcription at only four of the 275 genes (specifically, *NBPF12*, *SLC4A8*, *FA2H*, and *TIMM50*). Thus, the function of LTR5HS as alternative promoters cannot broadly explain the observed regulatory effects on host gene transcription.

Gene ontology analysis of the LTR5HS-regulated transcripts did not detect strong enrichments in specific biological processes and pathways (data not shown). Interestingly, however, even though our experiments were performed in NCCIT embryonal carcinoma cells, we analyzed previously published RNA-seq data and observed statistically significant relationships between LTR5HS-regulated transcripts and differentially expressed genes in these public datasets. Specifically, we found that 138 of the 275 LTR5HS-regulated transcripts (50%, Fisher's exact test p value = 2.63×10^−26^) are also upregulated in naïve as compared to primed hESCs ([Figure 4C](#fig4){ref-type="fig"}) ([@bib75]; [@bib76]), and that 55 of these transcripts (20%, Fisher's exact test p value = 3.85×10^−21^) are expressed in the human preimplantation epiblast ([Figure 4D](#fig4){ref-type="fig"}) ([@bib87]). These observations are consistent with potential LTR5HS-dependent gene regulation in naïve hESC and preimplantation embryos, where these elements undergo transcriptional reactivation ([@bib22]; [@bib76]). We next analyzed published single cell RNA-seq data from both human and rhesus macaque early embryos, and found that LTR5HS-regulated transcripts are more highly expressed in human than rhesus preimplantation blastocysts ([Figure 4E](#fig4){ref-type="fig"}; Wilcoxon-Mann-Whitney p value \< 0.001) ([@bib83]; [@bib87]). A trend towards human-specific upregulation of these transcripts can be observed starting at the 8-cell stage through the morula, although it only reaches statistical significance in the blastocyst ([Figure 4E](#fig4){ref-type="fig"}). Given that the rhesus genome does not contain any LTR5HS insertions, and that LTR5HS-driven expression in the developing human embryo begins at the 8-cell stage and peaks in the blastocyst ([@bib22]), these observations suggest that the acquisition of LTR5HS after the split of apes from old world monkeys has contributed to increased expression of a subset of preimplantation genes specifically in apes. We then analyzed the evolutionary age of the LTR5HS insertions closest to the LTR5HS-regulated transcripts (ranging from over 20 million years for the oldest elements to a couple of hundred thousand years for the youngest). We observed no bias for older insertions to be associated with regulatory changes ([Figure 4---figure supplement 1C and D](#fig4s1){ref-type="fig"}) and consequently, a subset of LTR5HS-regulated transcripts was linked to human-specific LTR5HS instances (i.e. those 5 million years old or younger). These observations raise the intriguing possibility that LTR5HS may mediate not only ape-specific, but also human-specific features of early embryonic gene regulation.

LTR5HS activation and repression affect host gene transcription over long genomic distances {#s2-5}
-------------------------------------------------------------------------------------------

A hallmark of enhancer elements is their ability to activate host gene expression over long genomic distances and in an orientation-independent manner. We noted that although most LTR5HS-regulated transcripts fell within the closest decile category with respect to distance from the nearest LTR5HS, this category encompassed distances of up to \~436 kb ([Figure 4B](#fig4){ref-type="fig"}). We therefore took an LTR5HS-centric approach, and examined changes in host gene expression in relation to distance from each gene transcription start site (TSS) to the nearest LTR5HS at higher resolution within the ±200 kb domain. We found that expression of genes with promoters located not only in direct proximity of LTR5HS, but up to \~200 kb upstream or downstream of LTR5HS, was significantly upregulated by recruitment of dCas9-VPR (CRISPRa) to LTR5HS (LTR5HS Sp), compared to controls (LTR5HS Sa and nontarget Sp), but at further distances the changes became non-significant ([Figure 5A](#fig5){ref-type="fig"}, see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for statistical analysis). We observed the opposite effect with recruitment of dCas9-KRAB (CRISPRi) to LTR5HS, with genes within \~200 kb upstream or downstream of LTR5HS elements, but not those further away, showing significant downregulation ([Figure 5B](#fig5){ref-type="fig"}, see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for statistical analysis). Thus, activation or repression of LTR5HS can exert long-range effects on host gene transcription, in agreement with the function of these elements as long-range enhancers.

![LTR5HS activation or repression affects host gene expression over long genomic distances.\
(**A--B**) Box plots of log2 fold change in gene expression between recruitment (LTR5HS Sp) and control (LTR5HS Sa and nontarget Sp) arrays in NCCIT cells induced with CRISPRa (**A**) or CRISPRi (**B**). (**C--D**) Box plots of log2 fold change in gene expression between naïve and primed hESC, using data from ([@bib76]) (**C**) and ([@bib75]) (**D**). For all box plots, genes are binned into 40 kb bins centered around the indicated integer by distance from the TSS to the center of the nearest LTR5HS insertion. Plots show median (center line), with interquartile range (box), and whiskers show points within 1.5x the interquartile range. Statistical significance analysis of observed changes for each bin and additional bins located at distances further away from LTR5HS is presented in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. (**E**) Heat maps of normalized ChIP-seq signal using antibodies against Cas9, H3K27ac, H3K4me3, or H3K9me3. Heat maps for each antibody show wild type NCCIT or NCCIT cells expressing dCas9-VPR or dCas9-KRAB fusion along with LTR5HS Sp CARGO array. Each row represents a 4 kb window (2 kb in each direction) centered around the TSS of the 275 LTR5HS-regulated genes (i.e. blue points in lower right quadrant of [Figure 4A](#fig4){ref-type="fig"}). All heat maps are sorted by H3K27ac signal in WT NCCIT.](elife-35989-fig5){#fig5}

Given that many LTR5HS-regulated transcripts are also differentially expressed between naïve and primed hESC ([Figure 4C](#fig4){ref-type="fig"}) and that LTR5HS appears to be selectively active in naïve as compared to primed hESC ([@bib22]), we used publicly available data from ([@bib76]) and ([@bib75]) to probe the relationship between the distance from the LTR5HS and changes in expression between naïve and primed hESC. We observed naïve state-biased expression of genes located up to 40--120 kb away from the LTR5HS, depending on the dataset used for the analysis ([Figure 5C--D](#fig5){ref-type="fig"}, see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for statistical analysis).

In contrast, we found more limited impact on transcription of genes near LTR5A and LTR5B, where only local effects can be detected ([Figure 5---figure supplement 1A--D](#fig5s1){ref-type="fig"}). Given that 53% of LTR5A regions and 41% of LTR5B regions are bound by dCas9 ([Figure 2D](#fig2){ref-type="fig"}), this suggests that LTR5A/B insertions likely do not have robust long-range enhancer activity in NCCIT cells, although we cannot exclude the possibility that the weaker transcriptional effects are associated with lower enrichments of dCas9 fusion proteins at these elements. Nonetheless, LTR5HS, which contains an OCT4 motif, is preferentially bound by OCT4 and p300 as compared to LTR5A and LTR5B, which do not contain the motif ([@bib22]; [@bib88]). We also analyzed publicly available ChIP-seq data and observed OCT4 and H3K27ac enrichments at LTR5HS in NCCIT and naïve hESC, but not primed hESC, while no enrichments were detected at LTR5A or LTR5B ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). These data suggest that genuine functional differences in regulatory capacity exist within distinct subclasses of HERVK LTR5 elements, and that their regulatory activity is cell type-specific. As a control, we analyzed gene expression changes under CRISPRa and CRISPRi conditions with respect to distance from HERVE LTR2, a class of LTR that is not targeted in these experiments. As expected, we found no effect on genes near this LTR class, confirming that the transcriptional changes observed are dependent on specific targeting of HERVK LTR5HS ([Figure 5---figure supplement 1E--F](#fig5s1){ref-type="fig"}).

We next sought to determine if transcriptional changes observed at the LTR5HS-regulated genes under CRISPRa and CRISPRi conditions are accompanied by differences in histone modifications at the promoters of these genes. We used the histone modification ChIP-seq data described above to examine patterns of H3K27ac, H3K9me3, and H3K4me3 surrounding the promoters of the 275 LTR5HS-regulated transcripts (i.e. blue points in lower right quadrant of [Figure 4A](#fig4){ref-type="fig"}). Most of these promoters are marked by at least some H3K27ac and H3K4me3 in WT NCCIT, and most gain or lose, respectively, H3K27 acetylation under CRISPRa or CRISPRi conditions ([Figure 5E](#fig5){ref-type="fig"}). Notably, these changes occur in the absence of direct dCas9 binding to the promoters, suggesting that they result from the long-range effects of LTR5HS ([Figure 5E](#fig5){ref-type="fig"}). Furthermore, although some gains of H3K9me3 can be observed in the vicinity of the promoters under CRISPRi conditions, most TSS remain unmethylated at H3K9, and, unlike at the LTRs, their H3K4me3 levels are relatively unaffected, suggesting that direct silencing of promoters via H3K9me3 spreading from a nearby LTR5HS is not likely to explain the transcriptional effects we examine in this study. As a control, we performed these same analyses on a set of 275 random promoters, and we detected no changes in any histone mark under CRISPRa or CRISPRi conditions ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).

Long-range effects on host gene expression are dependent on LTR5HS DNA sequence {#s2-6}
-------------------------------------------------------------------------------

We next sought to test whether the presence of LTR5HS DNA sequences is required for both the deposition of enhancer marks in the vicinity of the LTR5HS and for the observed long-range effects on host gene expression. To this end, we selected six genes, *CACNAD2D*, *EPHA7*, *ALPPL2*, *NFKB2*, *SERPINB9*, and *GDPD1*, that: (i) were among the 275 LTR5HS-regulated genes with reciprocal effects on expression upon CRISPRa/CRISPRi, (ii) contained no more than two LTR5HS within 1 Mb of the TSS, (iii) spanned a large range of promoter distances from LTR5HS (e.g. from \~2 kb for the closest to \~245 kb for the most distal), and (iv) represented all potential combinations of position relative to the promoter as well as orientation of LTR5HS-driven transcription with respect to the gene. We deleted the nearest LTR5HS element at each selected locus via CRISPR/Cas9 genome editing using WT NCCIT cells as a parental cell line.

We first performed ChIP-qPCR for the histone modifications H3K27ac and H3K4me1 on multiple clonal lines with or without the LTR5HS deletions at three of these loci: *CACNA2D2*, *EPHA7*, and *ALPPL2*. We found that upon deletion of the LTR5HS, both H3K27ac and H3K4me1 were significantly reduced in the regions directly flanking the LTR5HS insertion, consistent with the idea that the presence of the LTR5HS sequence is required for the deposition of these marks ([Figure 6A](#fig6){ref-type="fig"}). We also found that H3K27ac is significantly reduced at the promoter of two of these three genes (*EPHA7* and *ALPPL2*) upon deletion of the LTR5HS ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), which indicates that the presence of the distal LTR5HS sequence has a direct effect on the chromatin state of the gene's promoter.

![Contribution of LTR5HS sequences to chromatin marking and host gene expression.\
(**A**) ChIP-qPCR analysis for H3K27ac and H3K4me1 on multiple clonal lines with or without the LTR5HS deletions at indicated gene loci. Regions directly flanking the LTR5HS were analyzed for ChIP signal enrichment over two negative regions. Average signals obtained across indicated number of clones are shown. (**B**) RT-qPCR analysis of LTR5HS-regulated transcripts in multiple clonal lines with or without the LTR5HS deletions at indicated gene loci. Average expression of each gene across indicated number of clones is shown, measured relative to two housekeeping genes, *RPL13A* and *TBP*. Above each plot in (**B**), diagram showing TSS and nearest LTR5HS is shown to scale. Arrows show direction of transcription of coding genes and LTR5HS elements. For both (**A**) and (**B**), clones are either WT (black) or deleted for the nearest LTR5HS (LTR5HS highlighted in pink and marked with an 'X' in top panels of \[B\]) by CRISPR/Cas9 genome editing (gray). Error bars show standard deviation. \*p value \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; \*\*\*\*p \< 0.0001, one-sided *t*-test.](elife-35989-fig6){#fig6}

Next, we measured the expression of each of the six genes across multiple clonal NCCIT lines with or without the deletion of the nearest LTR5HS ([Figure 6B](#fig6){ref-type="fig"}). For all six genes, we observed a significant decrease in expression upon deletion of the nearest LTR5HS. For *CACNA2D2*, we observed an average of \~2.6-fold decrease in expression upon deletion of the nearest LTR5HS, which is human-specific, located \~16.7 kb upstream of the TSS, and transcribed in a divergent orientation with respect to the gene (n = 6 LTR5HS deleted clones; 10 LTR5HS WT clones; [Figure 6B](#fig6){ref-type="fig"}). We found an average of \~8.1-fold decrease in expression after deleting the LTR5HS element closest to *EPHA7*, which is also human-specific, located \~245 kb downstream of the TSS, and transcribed in a convergent orientation towards the gene (n = 3 LTR5HS deleted clones; 15 LTR5HS WT clones). For *ALPPL2*, we measured an average of \~3.3-fold decrease in expression with deletion of the nearest LTR5HS, which is also human specific, located \~16 kb downstream of the TSS, and transcribed in the same orientation as the gene (both are on the Watson strand) (n = 7 LTR5HS deleted clones, 27 LTR5HS WT clones). We similarly observed an average of \~6.9-fold decrease in expression after deleting the LTR5HS element nearest to *NFKB2*, \~2.1 kb upstream of the TSS and transcribed in the same orientation as the gene (both are on the Watson strand) (n = 5 LTR5HS deleted clones; 11 LTR5HS WT clones). We found an average of \~7.0-fold loss of expression of *SERPINB9* upon deletion of the nearest LTR5HS element, \~5.8 kb upstream of the TSS and transcribed in a divergent orientation with respect to the gene (n = 3 LTR5HS deleted clones; 7 LTR5HS WT clones). Finally, upon deletion of the LTR5HS closest to *GDPD1*, \~69 kb downstream of the TSS and transcribed in a convergent orientation towards the gene, we found an average of \~3.2-fold loss of expression of the gene (n = 2 LTR5HS deleted clones, 17 LTR5HS WT clones; [Figure 6B](#fig6){ref-type="fig"}). These results demonstrate that long-range effects on gene regulation are directly dependent on LTR5HS DNA sequences and show that a single promoter-distal LTR can provide a very strong contribution to the overall gene activity.

Discussion {#s3}
==========

Our study demonstrates a proof of principle for combining CARGO with CRISPRa/CRISPRi to simultaneously target hundreds of repetitive elements across the genome and manipulate their function. While we focused on HERVK LTR5HS, the strategy described here could be easily adapted to study different classes of TEs. We exploited the sequence similarity of LTR5HS insertions to target hundreds of insertions with only twelve gRNAs, with most insertions being targeted by multiple gRNAs. Given that CARGO can easily deliver 36 or more gRNAs to single cells ([@bib23]), our approach is applicable for targeting TEs that are more sequence-divergent and/or present in higher copy numbers than LTR5HS. Furthermore, different dCas9 fusions could replace the dCas9-VPR and dCas9-KRAB fusions used in this work. These could potentially enable imaging at these loci ([@bib11]; [@bib23]) or local manipulation of DNA or histone modifications ([@bib30]; [@bib41]; [@bib48]; [@bib51]; [@bib80]; [@bib86]).

The findings that CRISPRa/CRISPRi reciprocally affects expression and promoter histone modification patterns of genes located tens or even several hundreds of kilobases away from LTR5HS elements, and that CRISPR/Cas9 deletion of individual LTR5HS insertions substantially decreases expression of nearby host genes spanning a wide range of distances and distinct orientations with respect to the LTR, altogether indicate that these insertions act as enhancer elements. While multiple recent studies demonstrated the presence of enhancer chromatin signatures at various classes of LTRs, correlated them with expression of nearby genes, or directly demonstrated the importance of select individual LTR instances for host gene activity ([@bib15]; [@bib13]; [@bib22]; [@bib76]; [@bib78]; [@bib81]), to our knowledge this study is the first to systematically interrogate the function of a specific LTR class in long-range gene regulation. We uncovered a broad impact of LTR5HS on host gene transcription, with 275 genes being reciprocally up- or down-regulated in our CRISPRa/CRISPRi experiments. Given the widespread redundancies in mammalian regulatory landscapes where loss of a single enhancer often has only a minor influence on expression ([@bib27]; [@bib31]; [@bib56]; [@bib58]), the transcriptional effects we observe upon deletion of single LTR5HS elements are surprisingly potent, suggesting that these elements indeed function as strong and/or relatively non-redundant enhancers of their target genes.

Considering that other classes of TEs beyond LTR5HS are likely contributing to gene regulation in the early human embryo, these observations are consistent with a pervasive, rather than occasional, role of TEs in transcriptional control. In the mouse, MERVL elements in 2C stage embryos function as alternative promoters ([@bib53]), and, so far, no evidence exists to suggest that they may act as transcriptional enhancers. Hundreds of chimeric transcripts spanning junctions between 5ʹ ERV LTRs and exons containing open reading frames were detected in these cells. However, we found no evidence of pervasive chimeric transcription between HERVK LTR5HS insertions and nearby host genes ([@bib22] and this study), illustrating diverse mechanisms that may underlie regulatory functions in the early embryo.

Although the fact that evolutionarily young LTRs such as LTR5HS have been so extensively adapted for enhancer function may seem counterintuitive, it is important to note that preimplantation embryo cells and germ cells may be a privileged environment for such early adaptation, not only due to global DNA hypomethylation in these cells, but because in order to persist through vertical transmission, these ancient retroviruses must have been able to replicate in the germline or early embryonic cells, before the germline has been set aside. Thus, LTRs of retroviruses that successfully endogenized might have been optimized to begin with for directing expression in early embryo/germ cells. Interestingly, LTR5HS elements (but not related LTR5A/B elements) contain a consensus motif and are bound by the pluripotent stem cell/primordial germ cell/reprogramming factor and master regulator OCT4, which may have contributed both to their endogenization and cooption for enhancer function ([@bib22] and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Indeed, OCT4 plays a central role in activating pluripotency network enhancers ([@bib8]; [@bib16]) and our previous work demonstrated that its binding motif is important for the ability of LTR5HS to drive transcription ([@bib22]).

It is intriguing to consider whether regulatory repurposing of LTR5HS elements for enhancer function may have contributed to human-specific transcriptome divergence and endowed the early developmental stages of the human embryo with species-specific attributes. All LTR5HS insertions are unique to apes, and a subset is human-specific or even human-polymorphic ([@bib4]; [@bib71]; [@bib73]; [@bib84]). We found that both human-specific and older, ape-specific LTR5HS elements contribute to long-range gene regulation, and that some of the genes dependent on them in embryonal carcinoma cells are also expressed in human preimplantation embryos. Interestingly, we found that transcript levels of genes that are orthologous between human and rhesus macaque and regulated by LTR5HS in human cells are significantly elevated in human blastocysts compared to rhesus blastocysts. Given that rhesus diverged from the human lineage approximately 25 million years ago ([@bib68]), before the integration of LTR5HS, our findings suggest that a recent burst of HERVK endogenization supplied humans and other apes with new early embryonic enhancers, leading to a shift in preimplantation gene expression programs. Although there is no evidence thus far to suggest that the phenotypic consequences of the molecular adaptation of LTR5HS for enhancer function have been beneficial to the host, it is nonetheless tempting to speculate that some LTR5HS-driven changes in gene expression may have measurable phenotypic consequences on early development, endowing it with ape-specific attributes. Regardless, the CARGO-CRISPRa/CRISPRi strategy described here provides a novel tool to study the impact of LTRs and other TEs on primate-specific features of development and disease.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\    Designation                                                           Source or reference   Identifiers                                                    Additional information
  or resource                                                                                                                                                                           
  -------------------------- --------------------------------------------------------------------- --------------------- -------------------------------------------------------------- -----------------------------------------------------------------------
  Cell line (*H. sapiens*)   NCCIT                                                                 ATCC                  ATCC:CRL-2073;\                                                
                                                                                                                         RRID:[CVCL_1451](https://scicrunch.org/resolver/CVCL_1451)     

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitors:\
  (*H. sapiens*)             dCas9-VPR                                                                                                                                                  NCCIT, PiggyBac transposon

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitors:\
  (*H. sapiens*)             dCas9-KRAB                                                                                                                                                 NCCIT, PiggyBac transposon

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitors:\
  (*H. sapiens*)             dCas9-GFP                                                                                                                                                  NCCIT, PiggyBac transposon

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-VPR LTR5HS\                                                                                                                                          NCCIT PiggyBac dCas9-VPR
                             *S. pyogenes*                                                                                                                                              

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-VPR LTR5HS\                                                                                                                                          NCCIT PiggyBac dCas9-VPR
                             S. *aureus*                                                                                                                                                

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-VPR nontarget\                                                                                                                                       NCCIT PiggyBac dCas9-VPR
                             *S. pyogenes*                                                                                                                                              

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-KRAB LTR5HS\                                                                                                                                         NCCIT PiggyBac dCas9-KRAB
                             *S. pyogenes*                                                                                                                                              

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-KRAB LTR5HS\                                                                                                                                         NCCIT PiggyBac dCas9-KRAB
                             *S. aureus*                                                                                                                                                

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-KRAB nontarget\                                                                                                                                      NCCIT PiggyBac dCas9-KRAB
                             *S. pyogenes*                                                                                                                                              

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-GFP LTR5HS\                                                                                                                                          NCCIT PiggyBac dCas9-GFP
                             *S. pyogenes*                                                                                                                                              

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-GFP LTR5HS\                                                                                                                                          NCCIT PiggyBac dCas9-GFP
                             *S. aureus*                                                                                                                                                

  Transfected construct\     NCCIT PiggyBac\                                                       this paper                                                                           Progenitor:\
  (*H. sapiens*)             dCas9-GFP nontarget\                                                                                                                                       NCCIT PiggyBac dCas9-GFP
                             *S. pyogenes*                                                                                                                                              

  Antibody                   HERVK env                                                             Austral Biologicals   Austral Biologicals:\                                          See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                                         HERM-1811--5                                                   

  Antibody                   RNA pol II\                                                           Biolegend             Biolegend:920101;\                                             See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                             (clone 8WG16)                                                                               RRID:[AB_2565317](https://scicrunch.org/resolver/AB_2565317)   

  Antibody                   Cas9\                                                                 Active Motif          Active Motif:61757                                             See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                             (clone 8C1-F10)                                                                                                                                            

  Antibody                   GFP                                                                   Abcam                 Abcam:ab290;\                                                  See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                                         RRID:[AB_303395](https://scicrunch.org/resolver/AB_303395)     

  Antibody                   GFP                                                                   Thermo Fisher\        Thermo Fisher\                                                 See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                   Scientific\           Scientific (Invitrogen):\                                      
                                                                                                   (Invitrogen)          A-11122;\                                                      
                                                                                                                         RRID:[AB_221569](https://scicrunch.org/resolver/AB_221569)     

  Antibody                   H3K27ac                                                               Active Motif          Active Motif:39133;\                                           See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                                         RRID:[AB_2561016](https://scicrunch.org/resolver/AB_2561016)   

  Antibody                   H3K4me3                                                               Active Motif          Active Motif:39159;\                                           See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                                         RRID:[AB_2615077](https://scicrunch.org/resolver/AB_2615077)   

  Antibody                   H3K9me3                                                               Abcam                 Abcam:ab8898;\                                                 See [Supplementary file 2](#supp2){ref-type="supplementary-material"}
                                                                                                                         RRID:[AB_306848](https://scicrunch.org/resolver/AB_306848)     

  Recombinant DNA\           PiggyBac transposon                                                   System Biosciences                                                                   
  reagent                                                                                                                                                                               

  Recombinant DNA\           px332                                                                 PMID:\                                                                               
  reagent                                                                                          29371426                                                                             

  Recombinant DNA\           LTR5HS *S. pyogenes*\                                                 this paper                                                                           Progenitors: PiggyBac\
  reagent                    scaffold CARGO array                                                                                                                                       transposon, px332; targeting\
                                                                                                                                                                                        array (LTR5HS gRNAs)

  Recombinant DNA\           LTR5HS *S. aureus*\                                                   this paper                                                                           Progenitors: PiggyBac\
  reagent                    scaffold CARGO array                                                                                                                                       transposon, px332; control\
                                                                                                                                                                                        array (LTR5HS gRNAs)

  Recombinant DNA\           nontarget *S. pyogenes*\                                              this paper                                                                           Progenitors: PiggyBac\
  reagent                    scaffold CARGO array                                                                                                                                       transposon, px332; control\
                                                                                                                                                                                        array (nontargeting gRNAs)

  Recombinant DNA\           px458 GFP                                                             PMID:\                Addgene:48138                                                  
  reagent                                                                                          24157548                                                                             

  Recombinant DNA\           px458 mCherry                                                         this paper                                                                           Progenitor: px458 GFP
  reagent                                                                                                                                                                               

  Recombinant DNA\           PiggyBac dCas9-VPR                                                    this paper                                                                           Progenitor:\
  reagent                                                                                                                                                                               PiggyBac transposon

  Recombinant DNA\           PiggyBac dCas9-KRAB                                                   this paper                                                                           Progenitor:\
  reagent                                                                                                                                                                               PiggyBac transposon

  Recombinant DNA\           PiggyBac dCas9-GFP                                                    this paper                                                                           Progenitor:\
  reagent                                                                                                                                                                               PiggyBac transposon

  Sequence-based\            RT-qPCR primers\                                                      this paper                                                                           
  reagent                    ([Supplementary file 2](#supp2){ref-type="supplementary-material"})                                                                                        

  Sequence-based\            ChIP-qPCR primers\                                                    this paper                                                                           
  reagent                    ([Supplementary file 2](#supp2){ref-type="supplementary-material"})                                                                                        

  Sequence-based\            CARGO CRISPR\                                                         this paper                                                                           
  reagent                    gRNAs\                                                                                                                                                     
                             ([Supplementary file 2](#supp2){ref-type="supplementary-material"})                                                                                        

  Sequence-based\            LTR5HS deletion CRISPR\                                               this paper                                                                           
  reagent                    gRNAs\                                                                                                                                                     
                             ([Supplementary file 2](#supp2){ref-type="supplementary-material"})                                                                                        

  Commercial\                Lonza MycoAlert                                                       Lonza                 Lonza:LT07-418                                                 
  assay or kit                                                                                                                                                                          

  Chemical compound,\        Doxycycline hyclate                                                   Sigma-Aldrich         Sigma-Aldrich:D9891                                            
  drug                                                                                                                                                                                  

  Chemical compound,\        Puromycin                                                             InvivoGen             InvivoGen:ant-pr-1                                             
  drug                                                                                                                                                                                  

  Chemical compound,\        G418                                                                  Thermo Fisher\        Thermo Fisher\                                                 
  drug                                                                                             Scientific            Scientific:10131--035                                          

  Software, algorithm        CRISPOR                                                               PMID:\                                                                               
                                                                                                   27380939                                                                             

  Software, algorithm        Bowtie                                                                PMID:\                                                                               
                                                                                                   19261174                                                                             

  Software, algorithm        Bedtools                                                              PMID:\                                                                               
                                                                                                   25199790                                                                             

  Software, algorithm        FastQC                                                                Other                                                                                <https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>

  Software, algorithm        Bowtie2                                                               PMID:\                                                                               
                                                                                                   22388286                                                                             

  Software, algorithm        Samtools                                                              PMID:\                                                                               
                                                                                                   19505943                                                                             

  Software, algorithm        Picard tools                                                          Other                                                                                <https://broadinstitute.github.io/picard/>

  Software, algorithm        macs2                                                                 PMID:\                                                                               
                                                                                                   18798982                                                                             

  Software, algorithm        Deeptools                                                             PMID:\                                                                               
                                                                                                   27079975                                                                             

  Software, algorithm        HOMER                                                                 PMID:\                                                                               
                                                                                                   20513432                                                                             

  Software, algorithm        cutadapt                                                              Other                                                                                <https://github.com/marcelm/cutadapt>

  Software, algorithm        hisat2                                                                PMID:\                                                                               
                                                                                                   25751142                                                                             

  Software, algorithm        featurecounts                                                         PMID:\                                                                               
                                                                                                   24227677                                                                             

  Software, algorithm        DESeq2                                                                PMID:\                                                                               
                                                                                                   25516281                                                                             

  Software, algorithm        Tophat2                                                               PMID:\                                                                               
                                                                                                   23618408                                                                             

  Software, algorithm        skewer                                                                PMID:\                                                                               
                                                                                                   24925680                                                                             

  Software, algorithm        StringTie                                                             PMID:\                                                                               
                                                                                                   25690850                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cell culture {#s4-1}
------------

NCCIT cells were obtained from ATCC. NCCIT cells were grown in RPMI-1640 (Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Omega Scientific, Tarzana, CA, USA), 1x Glutamax (Thermo Fisher Scientific), 1x non-essential amino acids (Thermo Fisher Scientific), and 1x antibiotic/antimycotic (Thermo Fisher Scientific). Cell lines were tested for mycoplasma contamination using MycoAlert Detection Kit (Lonza, Basel, Switzerland). All cell lines tested negative for mycoplasma contamination.

LTR5HS-targeting CRISPR gRNA design {#s4-2}
-----------------------------------

All unique SpCas9 16 nt seed sequences derived from known instances of LTR5HS were aligned against hg38 human genome with bowtie ([@bib47]) using '-v' mode with up to three mismatches allowed. Alignments to LTR5HS, LTR5A and LTR5B were not counted as off-targets. The twelve guides with lowest off-target rate were selected for the targeting array. Non-targeting guides were taken from ([@bib70]).

LTR5HS gRNA analysis {#s4-3}
--------------------

For analysis shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, to identify potential binding sites for LTR5HS-targeting gRNAs in silico, Repeatmasker table was downloaded from UCSC table browser hg38, converted to BED format, and subsetted for specific analyses. Specifically, records for LTR5HS, LTR5A, and LTR5B were extracted into separate BED files, then FASTA files for these files were extracted using bedtools getfasta function ([@bib63]). Bowtie indices were built for these FASTA files, and the set of LTR5HS-targeting gRNAs was aligned to each LTR5x index allowing 0, 1, 2, or 3 mismatches, with 'bowtie -S -f -a -v {0, 1, 2, or 3} \$index guides.fa \> aligned.sam' used as the exact command. SAM files were converted to BED using bedtools bamtobed function, then the PAM sequence for each alignment was extracted using bedtools getfasta function. Only guide alignments followed by the PAM sequence 'NGG' were counted.

CARGO assembly {#s4-4}
--------------

CARGO arrays containing twelve guides were assembled as described previously ([@bib23]). The 12 gRNA transcriptional units of the CARGO plasmid were inserted into a PiggyBac transposon plasmid (System Biosciences, Palo Alto, CA, USA) containing a neomycin-selectable cassette by traditional cloning.

Plasmids {#s4-5}
--------

For CRISPRa/CRISPRi, dCas9-VPR, dCas9-KRAB, and dCas9-GFP fusions were inserted into a PiggyBac transposon containing a puromycin-selectable cassette. For CRISPR/Cas9 deletion of LTR5HS, a guide upstream of a targeted LTR5HS insertion was cloned into px458 (pSpCas9(BB)−2A-GFP, a gift from Feng Zhang, Addgene plasmid \#48138) ([@bib66]), which expresses Cas9 and GFP, and a guide downstream of a targeted LTR5HS insertion was cloned into a modified px458 plasmid which expresses mCherry instead of GFP.

Generation of stable lines {#s4-6}
--------------------------

NCCIT cells were transfected with PiggyBac plasmids containing a dox-inducible dCas9 fusion, along with PiggyBac transposase, and selected using puromycin (Invivogen, San Diego, CA, USA). These lines were then transfected with PiggyBac CARGO plasmids, along with PiggyBac transposase, and selected using G418 (Thermo Fisher Scientific). Cells were re-selected with puromycin (Invivogen) to ensure that dCas9-fusions were not lost during second transposition event. For all dCas9 fusion experiments, expression of fusion proteins was induced for four days with 2 ug/mL doxycycline (Sigma-Aldrich, St. Louis, MO, USA)

RNA extraction {#s4-7}
--------------

Cells for RT-qPCR and RNA-seq were homogenized in Trizol (Thermo Fisher Scientific), then RNA was extracted using Direct-zol RNA columns (Zymo Research, Irvine, CA, USA), with DNase treatment on-column, and eluted in water.

Reverse transcription for RT-qPCR {#s4-8}
---------------------------------

Reverse transcription for RT-qPCR was performed using SensiFAST cDNA synthesis kit (Bioline, Taunton, MA, USA), according to the manufacturer's instructions with input from the RNA extraction described above.

qPCR {#s4-9}
----

qPCR was performed using SensiFAST SYBR No-Rox kit (Bioline) in a LightCycler 480II (Roche, Basel, Switzerland), using technical duplicates or triplicates for each sample. Each condition was also analyzed with at least two independent biological replicates. Figure legends indicate transcript normalization for RT-qPCR.

Protein extraction and western blotting {#s4-10}
---------------------------------------

Whole cell nuclear extracts were prepared by lysing cells for 30 min at 4° C with overhead vertical rotation in protein extraction buffer (300 mM NaCl, 100 mM Tris pH 8, 0.2 mM EDTA, 0.1% Triton X-100, 10% glycerol, with 1x cOmplete EDTA-free protease-inhibitor cocktail \[Roche\]), then clearing by centrifugation and recovery of the supernatant. Total protein concentration was quantified by Bradford assay (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were denatured in LDS buffer (Thermo Fisher Scientific) supplemented with 2-mercaptoethanol (Sigma-Aldrich), then loaded in 3-fold serial dilutions onto tris-glycine 4--20% SDS-PAGE denaturing gradient gels (Thermo Fisher Scientific), then transferred onto nitrocellulose membrane. Chemiluminescence was assayed using Lumi-light Plus (Roche) or Amersham (GE Life Sciences, Pittsburgh, PA, USA) and visualized on autoradiography film.

Chromatin immunoprecipitation {#s4-11}
-----------------------------

ChIP assays were performed as described previously ([@bib64]). Briefly, approximately 10^7^ NCCIT cells were fixed in 1% formaldehyde for 10 min at room temperature in PBS, then quenched with glycine to a final concentration of 0.125 M for 10 min. Chromatin was sonicated to 0.5--2.0 kb using Bioruptor (Diagenode, Liège, Belgium), cleared by centrifugation, divided into separate aliquots for each antibody, and incubated with 5 μg of antibody overnight at 4° C. Subsequently, 100 μL of Dynabeads protein G (Thermo Fisher Scientific) were added to the ChIP reactions and incubated for 4--6 hr at 4° C. Magnetic beads were washed and chromatin was eluted, followed by reversal of crosslinks overnight at 65° C, proteinase K and RNase A treatment, and DNA purification by phenol/chloroform/isoamyl alcohol extraction and ethanol precipitation. ChIP DNA was resuspended in water.

Library preparation and sequencing for ChIP-seq {#s4-12}
-----------------------------------------------

For ChIP-seq data presented in [Figure 2](#fig2){ref-type="fig"} and its supplements, ChIP DNA (10 ng) was end-repaired, A-tailed, and ligated to NEBNext adapter for Illumina (New England Biolabs, Ipswich, MA, USA), followed by cleavage with USER enzyme (New England Biolabs). Adapter-ligated DNA was size-selected using a left/right AMPure XP size selection (Beckman Coulter, Brea, CA, USA). Size-selected DNA was amplified by qPCR using one universal primer and one indexed primer (New England Biolabs), then cleaned up with two AMPure XP cleanups. For ChIP-seq data presented in [Figure 3](#fig3){ref-type="fig"} and in [Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}, libraries were prepared using Ovation Ultralow System V2 UDI (NuGEN Technologies, San Carlos, CA, USA) according to manufacturer's instructions, starting with 10 ng of ChIP DNA. Library DNA was analyzed on Bioanalyzer DNA HS (Agilent, Santa Clara, CA, USA), then pooled and sequenced on a HiSeq 4000 (Illumina, San Diego, CA, USA) at the Stanford Genome Sequencing Service Center, using 2 × 150 bp sequencing with index read or dual index read.

Library preparation and sequencing for RNA-seq {#s4-13}
----------------------------------------------

Total RNA (10 ug) from two independent biological replicates was subjected to oligo-dT purification using Dynabeads oligo(dT) (Thermo Fisher Scientific), then fragmented with 10x fragmentation buffer (Thermo Fisher Scientific). Fragmented RNA was used for first strand cDNA synthesis with Superscript II (Thermo Fisher Scientific) and random hexamer primers (Thermo Fisher Scientific). Second strand cDNA synthesis was performed using RNase H (Thermo Fisher scientific) and DNA polymerase I (New England Biolabs). The resulting double-stranded cDNA was used for Illumina library preparation as described for ChIP-seq experiments, but was size-selected on acrylamide gels, and pooled and sequenced on a NextSeq 500 (Illumina) at the Stanford Functional Genomics Facility, using 2 × 150 sequencing with index read.

CRISPR/Cas9 deletion of LTR5HS {#s4-14}
------------------------------

gRNAs upstream and downstream of individual LTR5HS insertions with low potential off-targets were identified using CRISPOR ([@bib24]). For each deletion, two guides were selected, one upstream and one downstream of the LTR5HS. To avoid deletion of multiple LTR5HS, guides were chosen that do not overlap the LTR5HS. NCCIT cells were transfected with Lipofectamine 2000 (Thermo Fisher Scientific) with px458-GFP and px458-mCherry plasmids containing upstream and downstream gRNAs for a single LTR5HS insertion. 48 hr later, 1500 GFP- and mCherry- dual-fluorescent cells were sorted on a FACSAria II (BD Biosciences, San Jose, CA, USA), then plated onto a single well of a 6-well plate, coated with 10 ug/mL human plasma fibronectin (MilliporeSigma, Burlington, MA, USA). After \~5--7 days, individual colonies derived from single cells were picked and plated onto a single well of a 96-well fibronectin-coated plate. Cells were grown to confluency, then passaged, genotyped with DirectPCR Lysis Reagent (Viagen Biotech, Los Angeles, CA, USA) by PCR, and analyzed for gene expression by RT-qPCR. Multiple deletion and wild type clones for each LTR5HS insertion were analyzed, as indicated in [Figure 6B](#fig6){ref-type="fig"}. Each clone was analyzed at two separate passages.

ChIP-seq analysis {#s4-15}
-----------------

Quality of FASTQ files was assessed using FASTQC software. Reads were aligned to hg38 genome using bowtie2 ([@bib46]), with 'bowtie2 -p \$threads \--end-to-end \--no-mixed \--no-discordant \--minins 100 \--maxins 1000 -x hg38 −1 \$read1 −2 \$read2 \> aligned.sam' as the exact command for each sample. SAM files were converted to sorted, indexed, compressed BAM files using SAMtools ([@bib49]). Duplicate reads were removed using the MarkDuplicates function of Picard Tools. Macs2 ([@bib90]) callpeak function was used to call peaks for each ChIP (condition/antibody combination). For each ChIP with each antibody, peaks were called using that ChIP as the 'treatment' and the other two condition ChIPs as the 'control' for macs2, as previous studies have used other ChIP samples, Cas9 alone ChIPs, or ChIPs from cells not expressing Cas9 as controls ([@bib45]; [@bib61]; [@bib85]). Overlaps between ChIP peak calls were performed using bedtools intersect function. Deeptools command line tools ([@bib65]) was used to generate Bigwig plots for visualization of UCSC genome browser and ChIP-seq heat maps. HOMER software ([@bib28]) was used to associate dCas9 ChIP-seq peaks to different genomic features.

ChIP-seq to gRNA alignments correlation analysis {#s4-16}
------------------------------------------------

For analysis shown in [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, the BED file of all LTR5HS insertions was intersected with BED file containing three-antibody overlap ChIP-seq peak calls for LTR5HS Sp condition. Each LTR5HS insertion, along with the number of gRNAs expected to align to it (at 0, 1, 2, or 3 mismatches allowed), was therefore matched to the macs2 ChIP score at the same LTR5HS, and these are plotted as a violin point plot using the vpplot function of the vipor R package. Spearman correlation coefficient ρ is reported in the text.

RNA-seq analysis {#s4-17}
----------------

Quality of FASTQ files was assessed using FASTQC software. Reads from were trimmed of Illumina adapter sequences using cutadapt. For analysis of human non-repeat transcripts, trimmed reads were aligned using hisat2 ([@bib42]) to the hg38_tran index, with 'hisat2 -q -p \$threads -t \--no-mixed \--no-discordant -x hg38_tran −1 \$read1 −2 \$read2 -S aligned.sam' as the exact command for each sample. Reads were assigned to gene models using featureCounts ([@bib50]), and differential expression analysis was performed using DESeq2 ([@bib52]). For analysis of Repeatmasker transcripts, trimmed reads were aligned using TopHat2 ([@bib43]) to an index built from a FASTA file containing all Repeatmasker sequences, which was itself built using bedtools getfasta command with the Repeatmasker BED file described above. Reads were assigned to repeat models using featureCounts, then RPKM was calculated from these tabulations. For comparison of early embryo single cell RNA-seq, rhesus reads from ([@bib83]) were aligned to rheMac8, and human reads from ([@bib87]) were aligned to hg38 using hisat2, then reads were assigned to gene models using featureCounts. Ensembl BioMart was used to identify only genes with one-to-one orthology between the two species, and only these were used for further analyses. Transcripts per million (TPM) was calculated for each gene at each stage in each species. For chimeric transcript identification, RNA-seq reads were trimmed with skewer ([@bib38]) and aligned to GRCh38_p7 assembly with hisat2 with the following settings: \--dta \--no-mixed \--no-discordant. Transcript models were built based on this alignment with StringTie ([@bib60]) and annotated with gffcompare using gencode25 transcript models. Spliced transcripts originating in or within 100 bp of LTR5HS were treated as chimeric transcripts. TPM corresponding to expression level of the known and new transcripts were calculated with separate StringTie run for each library alignment (stringtie -e -B -A).

Unique mappability to LTR5HS {#s4-18}
----------------------------

All possible 150 bp paired-end reads for fragments in size range 150--400 bp within −400 bp to +400 bp of known LTR5HS were generated from hg38 reference sequence with bedtools getfasta and aligned to hg38 assembly with bowtie2 (\--end-to-end \--no-mixed \--no-discordant). MAPQ score for each pair was extracted and assigned to LTR5HS instance. Plot of fraction of uniquely mappable (MAPQ \> 20) reads was generated in R.

Antibodies, primers, gRNAs {#s4-19}
--------------------------

All antibodies, primers, and gRNAs used in this study are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Data availability {#s4-20}
-----------------

Sequencing data have been deposited in GEO under accession code GSE111337.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Detlef Weigel as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Deborah Bourchis (Reviewer \#1); Cédric Feschotte (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this study, the question of the extent to which Transposable Elements and their relics in a genome have been adapted to influence \"host\" gene regulation is addressed. By adapting their recently published gRNA multiplexing CARGO method (Gu et al., 2018) the authors target dCAS9-fusion activator (VPR) or repressor (KRAB) proteins to the \~700 copies of the HERVK (HML-2), LTR5HS elements of the human genome (known to be expressed early on in human development). The authors examine the effects of this TE modulation on nearby gene expression in human embryonal carcinoma cells derived from a germ-line tumor (NCCIT). The authors report that activation/silencing of LTR5HS is associated with reciprocal up- and down-regulation of nearly 300 human genes, although the VPR activation shows more striking effects than KRAB repression. They go on to look at the range of impact that these LTR5HS elements have is up to 160kb, suggesting that they might be acting as potential enhancers. The authors also specifically delete three individual LTR5HS elements, and examine effects on nearby genes by qRT-PCR which points to their potential role in gene regulation.

This study is of a great interest for the field as it serves as an important demonstration that expression of hundreds of copies of a specific family of LTR retrotransposons can be efficiently modulated using dCas9 effectors and the recently developed CARGO system and it allows the impact of a whole LTR family on gene expression to be addressed in a systematic way. Although previous studies (Guallar et al.,; Ishiuchi et al.,; Jachowicz et al., 2017; Amabile et al., 2016 -- which should have been cited) have targeted whole TE families, the present study is one of the first to describe an in depth, genome-wide analysis of what the functional contribution of LTR elements might be for gene expression control across the human genome. The manuscript is well written, easy to read and the experiments are of high quality. There are however some important issues that the authors will need to address.

Essential revisions:

1\) The authors claim that the LTR5HS sequences they have affected are acting as enhancers. However, they need to prove this enhancer potential at the endogenous locations. As the study stands they cannot rule out that the elements are acting as alternative promoters, particularly as the three LTR5HS elements that they deleted were in close proximity (a few kb) to the associated genes. Several approaches can address this, as outlined in the reviewers\' comments. These include demonstrating enhancer orientation independence for the LTRs; presenting their analyses in Figure 4 using stranded information, and directionality of the LTR as well as clarifying distances from TSS; demonstrating that chimeric transcripts are not produced between the LTR5HS elements and the up-regulated genes in the CRISPRa approach using 5\'RACE or CAGE RNAseq; performing ChIP-PCR to examine enhancer marks such as H3K27ac, H3K122ac and H3K4me1 to see if their distributions change in wt versus LTR-deleted condition across at least two of the loci studied (enhancer, promoter, and LTR); performing deletion experiments for LTRs that are more distant to the misregulated genes identified; examining the effects both upstream and downstream of the genes.

2\) The authors should provide more information about the transcription factor and chromatin landscape of the LTR sequences. This could thus assess whether there is a pre-existing regulatory activity of individual LTR5HS elements in NCCIT cells that could influence the efficiency and outcomes of the CRISPRi/a assays.

3\) The repressive effects on neighbouring genes upon KRAB targeting is not clear (Figure 4B and supplementary figures). There are no statistics and the number of genes falling into different categories are not given; the effects on basal transciprition of CACNA2D2, *NFKB2* and SERPINB9 upon deletion of the unique LTR is not shown.

4\) Statistics need to be checked and included in several of the figures including Figure 4 above. The distance analyses lack statistics: how many genes per \'distance\' block were analysed? Are the changes in transcription statistically significant? How would this look with a negative control (e.g. another repeat)?

10.7554/eLife.35989.043

Author response

> Essential revisions:
>
> 1\) The authors claim that the LTR5HS sequences they have affected are acting as enhancers. However, they need to prove this enhancer potential at the endogenous locations. As the study stands they cannot rule out that the elements are acting as alternative promoters, particularly as the three LTR5HS elements that they deleted were in close proximity (a few kb) to the associated genes. Several approaches can address this, as outlined in the reviewers\' comments. These include demonstrating enhancer orientation independence for the LTRs; presenting their analyses in Figure 4 using stranded information, and directionality of the LTR as well as clarifying distances from TSS; demonstrating that chimeric transcripts are not produced between the LTR5HS elements and the up-regulated genes in the CRISPRa approach using 5\'RACE or CAGE RNAseq; performing ChIP-PCR to examine enhancer marks such as H3K27ac, H3K122ac and H3K4me1 to see if their distributions change in wt versus LTR-deleted condition across at least two of the loci studied (enhancer, promoter, and LTR); performing deletion experiments for LTRs that are more distant to the misregulated genes identified; examining the effects both upstream and downstream of the genes.

We thank the reviewers for this comment and agree that the claim that LTR5HS elements function as distal enhancers is central to the thesis of our manuscript, and thus should be further strengthened. We followed the reviewers' suggestions and took a multi-pronged approach to addressing this comment, as outlined below:

Demonstrating orientation independence for the LTR5HS effect on gene expression: We reanalyzed the data concerning the LTR5HS-regulated genes (as defined in Figure 4A of the revised manuscript) and their nearest LTR5HS insertion (the putative enhancer). We found that for these 275 genes, the nearest LTR5HS is upstream of the promoter in 150 cases, and downstream in 125 cases. This finding suggests that even downstream LTR5HS insertions can have a transcriptional effect on the gene, a finding not compatible with their function as alternative promoters. Importantly, we deleted three of those downstream LTR5HS insertions and confirmed that they indeed significantly affect expression of the candidate target gene (see next section for details). As LTR sequences do have a natural orientation, we also examined the relative orientation of the nearest LTR5HS for each of these genes. In the 150 cases where the LTR5HS insertion is upstream of the promoter, the LTR5HS insertion has the same orientation (both on the Watson strand or both on the Crick strand) 83 times, compared to 67 in the opposite orientation. In the 125 cases where the LTR5HS insertion is downstream, the insertion has the same orientation as the gene 48 times, compared to 77 in the opposite orientation. These findings together suggest that neither the relative position of the LTR5HS to the promoter, nor its orientation, determines its ability to effect a transcriptional change on the gene in question under CRISPRa or CRISPRi, consistent with the proposed enhancer function. This information has now been incorporated in the text of the revised manuscript under the header "Reciprocal effects of LTR5HS CRISPRa/CRISPRi on host gene expression."

Additional deletion experiments for LTRs that are more distant to the misregulated genes identified and located downstream from the TSS:

The reviewers suggested that the three LTR5HS elements deleted in our original manuscript were all *"in close proximity"* to the associated genes and thus may not be enhancers. First, we would like to clarify that since these LTRs were respectively \~17 kb, \~2 kb and \~6 kb upstream from the promoter, they all fall under the definition of distal regulatory elements, typically defined as those that do not overlap with promoter sequences (usually contained within 200-500 bp of the TSS). Furthermore, two of the genes (*SERPINB9* and *CACNA2D2*) are transcribed in opposite orientation relative to the LTR5HS, making their LTR5HS-originating chimeric transcription unlikely. Nonetheless, we agree that since all deleted elements were upstream from the target genes, additional deletions were needed to further exclude a possibility that the LTR5HS elements function as alternative promoters. In the revised manuscript, we present analysis of clonal lines with homozygous deletions of three LTR5HS elements located downstream from the candidate target genes: (i) \~16 kb downstream of the *ALPPL2* gene TSS, (ii) \~245 kb downstream of the *EPHA7* gene TSS (as this gene is long, the deletion is 65 kb downstream of the annotated transcription termination site \[TTS\]) and (iii) \~69 kb downstream of the *GDPD1* gene TSS. In all three cases, we observed downregulation of the candidate target gene (see Figure 6B in the revised manuscript). Together with our previous results, we now show examples of deletions of LTR5HS elements located within a wide distance range from the target gene promoter (e.g. from 2 kb for the closest to 245 kb for the most distal), positioned either upstream or downstream from the gene TSS and transcribed in either direction with respect to the gene. In all cases, we observed downregulation of the candidate target gene (Figure 6B), providing definitive evidence that LTR5HS elements indeed function as enhancers.

We also want to clarify (since there may have been some confusion, see essential revision point 3), that these deletion experiments were all performed in WT NCCIT cells that do not express any dCas9 fusions. We believe that the confusion might have been caused by our inclusion of the genome browser images with dCas9 binding at these selected LTRs in the figure, and thus we eliminated those browser images and reorganized the figure to incorporate new data.

ChIP-PCR analysis of enhancer marks in the LTR5HS deletion lines:

We performed ChIP-qPCR for the histone modifications H3K27ac and H3K4me1 in homozygous deletion and wild type clones for three separate LTR5HS insertions: those near *CACNA2D2, ALPPL2*, and *EPHA7*. In each case, we observe loss of both H3K27ac and H3K4me1 from the LTR5HS flanking regions in the deletion lines (shown in Figure 6A of the revised manuscript), demonstrating that deposition of these enhancer marks is dependent on the presence of the LTR sequence. Furthermore, analysis of the H3K27ac at the target gene promoters revealed downregulation of promoter acetylation levels in LTR5HS deletion lines, though we note that this downregulation did not reach statistical significance at one of the genes (Figure 6---figure supplement 1).

Analysis of chimeric transcripts between the LTR5HS elements and the upregulated genes: We analyzed deeply sequenced (\~500 million 150 bp paired-end reads) RNA-seq data for the presence of the chimeric transcripts between LTR5HS and 275 LTR5HS-regulated genes identified in our study. We detected an appreciable level (e.g. \> 1 TPM, transcript per million) of chimeric transcription at only four of the 275 genes (specifically, *NBPF12, SLC4A8, FA2H* and *TIMM50*). Notably, of the six LTR5HS elements that we deleted, all showed effect on candidate target gene expression, but none had detectable levels of chimeric transcription between the LTR5HS and the regulated gene. We therefore conclude that while such chimeric transcripts may indeed arise at some loci, they cannot explain the regulatory effects observed in our study. This information has been incorporated into the manuscript under the header, "Reciprocal effects of LTR5HS CRISPRa/CRISPRi on host gene expression."

> 2\) The authors should provide more information about the transcription factor and chromatin landscape of the LTR sequences. This could thus assess whether there is a pre-existing regulatory activity of individual LTR5HS elements in NCCIT cells that could influence the efficiency and outcomes of the CRISPRi/a assays.

To investigate the chromatin landscape of the LTR sequences, we performed ChIP-seq for H3K27ac, H3K4me3, and H3K9me3. In addition to doing these experiments in the parental WT NCCIT line, we also performed these ChIPs in lines expressing dCas9-VPR and dCas9-KRAB along with the LTR5HS *S. pyogenes* CARGO array (i.e. under targeting conditions). This experimental design allows us to not only examine the landscape in unperturbed NCCITs, but also to measure the effects of VPR activation and KRAB repression on the chromatin states. Results from these experiments are presented in a new figure (Figure 3 in the revised manuscript, subsequent figures have been renamed accordingly).

Briefly, our results can be summarized as follows:

H3K27ac, H3K4me3 and H3K9me3 patterns

A subset of LTR5HS elements is marked by H3K27ac and H3K4me3 in WT cells in the absence of perturbation, with H3K4me3 showing asymmetric distribution consistent with the direction of the LTR-driven transcription, as has previously been observed at promoters and highly transcribed enhancers. Under CRISPRa conditions, most (over 90%) LTR5HS elements gain high level of H3K27 acetylation, but interestingly, H3K4me3 levels remain relatively unaffected. Strong gains of H3K27ac occur even at those LTR5HS elements that have low/no endogenous acetylation, which may indicate that ectopic enhancer activation is relatively common and efficient with dCas9-VPR system. Conversely, under CRISPRi conditions, endogenous H3K27ac and H3K4me3 are suppressed, and most LTR5HS elements become decorated with high levels of H3K9me3, as would be expected, given that KRAB repression is mediated by the H3K9me3 deposition (Figure 3). Notably, in WT NCCIT cells, LTR5HS elements typically lack H3K9me3, regardless of the presence or absence of the active marks, suggesting that in these cells LTR5HS escapes KRAB-mediated repression, a major mechanism of endogenous retrovirus silencing.

In addition to examining histone modifications at LTR5HS insertions, we also assessed H3K27ac, H3K4me3, and H3K9me3 patterns surrounding the promoters of the 275 LTR5HSregulated transcripts (i.e. the genes activated by CRISPRa and repressed by CRISPRi, as defined in Figure 4A). We found that most of these promoters have at least some H3K27ac and H3K4me3 in WT cells, and most gain or lose, respectively, H3K27 acetylation under CRISPRa or CRISPRi conditions (new Figure 5E). Notably, these changes occur in the absence of direct dCas9 binding to the promoters, suggesting that they result from the long-range effects we describe. Furthermore, although some gains of H3K9me3 can be observed in the vicinity of the promoters under CRISPRi conditions, most of the TSS remain unmethylated at H3K9 and, unlike at the LTRs, their H3K4me3 levels are relatively unaffected, suggesting that direct silencing of promoters via H3K9me3 spreading from a nearby LTR5HS is not likely to explain the transcriptional effects we examine in this study. As a control, we performed these same analyses on a set of 275 randomly selected promoters, and we detected no changes in any histone mark under CRISPRa or CRISPRi conditions (Figure 5---figure supplement 3).

dCas9 binding patterns

We also performed ChIP-seq for dCas9-VPR and dCas9-KRAB fusions (in addition to the dCas9-GFP ChIP-seq reported in the original manuscript), as suggested in minor point 9. This experiment shows no dCas9 signal in WT (non-dCas9-expressing cells), but widespread binding to over 90% of LTR5HS in dCas9-VPR- and dCas9-KRAB-expressing cells (Figure 3A in the revised manuscript). We further observed that the dCas9-VPR levels at LTR5HS were higher than dCas9-KRAB levels. This is likely attributable to the fact that VPR, a strong activation domain, recruits coactivators that promote nucleosomal depletion, whereas KRAB-mediated H3K9me3 facilitates chromatin compaction, which may in turn provide, respectively, positive or negative feedback for dCas9 fusion binding. Nonetheless, dCas9-KRAB still occupies and mediates H3K9me3 deposition at the vast majority of LTR5HS elements (Figure 3A).

> 3\) The repressive effects on neighbouring genes upon KRAB targeting is not clear (Figure 4B and supplementary figures). There are no statistics and the number of genes falling into different categories are not given; the effects on basal transciprition of CACNA2D2, NFKB2 and SERPINB9 upon deletion of the unique LTR is not shown.

A discussion of statistics in Figure 4B (now Figure 5B in revised manuscript) follows in point 4. As for the effects on basal transcription of *CACNA2D2, NFKB2*, and *SERPINB9* upon deletion of the nearest LTR5HS, this result was shown in the initial manuscript in Figure 5C (now Figure 6B in revised manuscript). Again, perhaps due to our inclusion of the genome browser images with dCas9 binding at these selected LTRs, it was not clear to the reviewers that these deletion experiments were all performed in WT NCCIT cells that do not express any dCas9 fusions. In any case, as discussed above, we now extended the analysis to the additional three elements and show the effect of deletion of six different LTR5HS on the basal transcript levels of their candidate target genes (Figure 6B).

> 4\) Statistics need to be checked and included in several of the figures including Figure 4 above. The distance analyses lack statistics: how many genes per \'distance\' block were analysed? Are the changes in transcription statistically significant? How would this look with a negative control (e.g. another repeat)?

(Please note that Figure 4 from the initial submission is now Figure 5 in the revised manuscript.)

We analyzed a total of 26517 genes. These are broken down into 11 bins (-200, -160, -120, -80, 40, 0, 40, 80, 120, 160, 200). Each bin contains genes whose TSS is within +/- 20 kb of the bin description. Therefore, bin "0" contains genes whose TSS are between -20 and +20 kb from the nearest LTR5HS; bin "40" contains genes whose TSS are between +20 and +60 kb from the nearest LTR5HS; and so on. The number of genes per bin is as follows:

BinNumber of genesCRISPRa Wilcoxon signedrank test P-valueCRISPRi Wilcoxon signedrank test P-value-2002279.29e-035.20e-02-1602707.33e-082.06e-04-1202575.37e-074.63e-06-802991.78e-186.80e-11-403215.63e-362.24e-2304084.37e-521.31e-47402687.30e-313.64e-22803063.46e-239.15e-141202543.66e-114.11e-061602604.70e-062.01e-022002314.73e-066.12e-04

As for statistical significance, we have now performed one-sample Wilcoxon signed rank tests of the null hypothesis that the distribution of log2 fold change at each bin is symmetric around 0, which would describe no change in gene expression. Those values are indicated in the table above. We would like to point out that all bins we show reach statistical significance, including the +/-220-180 kb bins. However, if we perform significance testing on further bins, we show that log2FoldChange figures do fail to disprove the null hypothesis of the Wilcoxon signed rank test at bins further away. See below for results:

Bin (kb)Number of genesCRISPRa Wilcoxon signedrank test PvalueCRISPRi Wilcoxon signedrank test P-value-420 to -3801780.2910.002-380 to -3402030.0200.775-340 to -3001710.7620.100-300 to -2601970.0350.801-260 to -2202190.0540.014220 to 2602180.0360.028260 to 3002410.0050.043300 to 3401970.8510.132340 to 3802000.2970.456380 to 4202080.4990.669

These results have now been incorporated to the revised manuscript as Supplemental file 1. To further address the reviewer's point, as a negative control we generated similar plots of fold change under CRISPRa and CRISPRi, using an unrelated LTR, in this case LTR2 of the HERVE family, which has a similar number (\~900) of insertions as LTR5HS, but is not active in NCCIT cells. It is clear that there is no effect at any distance (see Figure 5---figure supplement 1E-F in the revised manuscript).
